BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 29679999)

  • 1. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
    Pham H; Sharma P
    Can J Urol; 2018 Apr; 25(2):9228-9237. PubMed ID: 29679999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
    Nguyen DD; Li T; Ferreira R; Baker Berjaoui M; Nguyen AV; Chughtai B; Zorn KC; Bhojani N; Elterman D
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):22-28. PubMed ID: 37081044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Madersbacher S; Roehrborn CG; Oelke M
    BJU Int; 2020 Sep; 126(3):317-326. PubMed ID: 32599656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and Emerging Technologies in Treatment of Lower Urinary Tract Symptoms From Benign Prostatic Hyperplasia.
    Gupta NK; Gange SN; McVary KT
    Sex Med Rev; 2019 Jul; 7(3):491-498. PubMed ID: 29606553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UroLift and Rezum: minimally invasive surgical therapies for the management of benign prostatic hyperplasia.
    Leong JY; Tokarski AT; Roehrborn CG; Das AK
    Can J Urol; 2021 Aug; 28(S2):2-5. PubMed ID: 34453421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
    Sønksen J; Barber NJ; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Montorsi F; Patterson JM; Fahrenkrug L; Schoenthaler M; Gratzke C
    Eur Urol; 2015 Oct; 68(4):643-52. PubMed ID: 25937539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis.
    Franco JVA; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    BJU Int; 2022 Aug; 130(2):142-156. PubMed ID: 34820997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia: an update on minimally invasive therapy including Aquablation.
    Das AK; Han TM; Uhr A; Roehrborn CG
    Can J Urol; 2020 Aug; 27(S3):2-10. PubMed ID: 32875996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic Urethral Lift Versus Transurethral Resection of the Prostate (TURP).
    Magistro G; Stief CG; Gratzke C
    Curr Urol Rep; 2017 Aug; 18(10):82. PubMed ID: 28852996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
    Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Kaufman RP; Badlani G; Plante M; Desai M; Doumanian L; Te AE; Roehrborn CG
    Can J Urol; 2022 Feb; 29(1):10960-10968. PubMed ID: 35150215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A state-of-art review on the preservation of sexual function among various minimally invasive surgical treatments for benign prostatic hyperplasia: Impact on erectile and ejaculatory domains.
    Ng BHS; Chung E
    Investig Clin Urol; 2021 Mar; 62(2):148-158. PubMed ID: 33660441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
    Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
    Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
    Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
    World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
    J Urol; 2016 May; 195(5):1529-1538. PubMed ID: 26614889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
    Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia?
    McVary KT; Rogers T; Mahon J; Gupta NK
    J Sex Med; 2018 Dec; 15(12):1728-1738. PubMed ID: 30446471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.
    Tanneru K; Jazayeri SB; Alam MU; Kumar J; Bazargani S; Kuntz G; Palayapalayam Ganapathi H; Bandyk M; Marino R; Koochekpour S; Gautam S; Balaji KC; Costa J
    J Endourol; 2021 Apr; 35(4):409-416. PubMed ID: 32962442
    [No Abstract]   [Full Text] [Related]  

  • 20. Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options.
    Liatsikos E; Kyriazis I; Kallidonis P; Stolzenburg JU
    Aging Male; 2011 Sep; 14(3):141-9. PubMed ID: 21247241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.